November 25, 2024 - 22:01
IceCure Medical Ltd. has announced that its next-generation multiprobe cryoablation technology has received a Notice of Allowance from Japan's Patent Office. This significant development marks a key milestone for the company's innovative approach to minimally invasive medical procedures.
The multiprobe cryoablation technology is designed to enhance the effectiveness and efficiency of cryoablation treatments, which are used to destroy abnormal tissues through extreme cold. This advancement is expected to provide physicians with improved tools for treating various medical conditions, potentially leading to better patient outcomes.
The approval from Japan's Patent Office underscores the technological advancements that IceCure is bringing to the field of cryoablation, positioning the company for growth in the competitive medical technology market.
September 18, 2025 - 02:23
Meta Introduces Innovative AI-Enhanced Smart GlassesIn a significant move towards integrating advanced technology into everyday life, Meta has unveiled a new range of AI-powered smart glasses. This launch comes at a time when the company is under...
September 17, 2025 - 19:35
Disparities in Health Technology Adoption Among Underserved HospitalsThe adoption of health information technology, including telehealth services and health information exchange systems, has seen a notable increase in recent years. However, hospitals located in the...
September 17, 2025 - 04:17
Chinese Tech Companies Surge Ahead with AI InvestmentCompanies in China’s technology sector have been raising billions in capital to advance their artificial intelligence capabilities and other digital infrastructure. This surge in fundraising...
September 16, 2025 - 23:15
Navigating Challenges: Tech Solutions in the Food IndustryDuring a recent panel discussion at FS/Tec, executives from notable brands such as Checkers & Rally`s, Shake Shack, and GoTo Foods shared insights into their strategic approaches to technology...